Garrison Point Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.56M | Sell |
12,116
-1,100
| -8% | -$129K | 0.63% | 45 |
|
|
2026
Q1 | $1.59M | Sell |
13,216
-1,099
| -8% | -$127K | 0.73% | 38 |
|
|
2025
Q4 | $1.51M | Sell |
14,315
-2,124
| -13% | -$199K | 0.67% | 39 |
|
|
2025
Q3 | $1.38M | Sell |
16,439
-1,254
| -7% | -$103K | 0.58% | 43 |
|
|
2025
Q2 | $1.4M | Buy |
17,693
+1
| +0% | +$79 | 0.64% | 41 |
|
|
2025
Q1 | $1.59M | Sell |
17,692
-909
| -5% | -$84.9K | 0.77% | 38 |
|
|
2024
Q4 | $1.85M | Buy |
18,601
+12,393
| +200% | +$1.28M | 0.88% | 29 |
|
|
2024
Q3 | $705K | Sell |
6,208
-600
| -9% | -$71.3K | 0.44% | 69 |
|
|
2024
Q2 | $843K | Sell |
6,808
-451
| -6% | -$58.1K | 0.56% | 55 |
|
|
2024
Q1 | $958K | Sell |
7,259
-154
| -2% | -$19K | 0.62% | 52 |
|
|
2023
Q4 | $808K | Sell |
7,413
-127
| -2% | -$13.2K | 0.57% | 60 |
|
|
2023
Q3 | $776K | Sell |
7,540
-99
| -1% | -$10.7K | 0.6% | 55 |
|
|
2023
Q2 | $881K | Sell |
7,639
-209
| -3% | -$23.7K | 0.64% | 50 |
|
|
2023
Q1 | $835K | Buy |
7,848
+2,578
| +49% | +$278K | 0.63% | 53 |
|
|
2022
Q4 | $585K | Sell |
5,270
-199
| -4% | -$20.3K | 0.48% | 76 |
|
|
2022
Q3 | $471K | Hold |
5,469
| – | – | 0.42% | 80 |
|
|
2022
Q2 | $499K | Buy |
5,469
+1
| +0% | +$89 | 0.41% | 78 |
|
|
2022
Q1 | $449K | Buy |
5,468
+1
| +0% | +$79 | 0.31% | 97 |
|
|
2021
Q4 | $419K | Buy |
5,467
+86
| +2% | +$6.85K | 0.28% | 102 |
|
|
2021
Q3 | $404K | Buy |
5,381
+1
| +0% | +$76 | 0.29% | 105 |
|
|
2021
Q2 | $418K | Sell |
5,380
-121
| -2% | -$9K | 0.3% | 102 |
|
|
2021
Q1 | $405K | Buy |
5,501
+286
| +5% | +$21.1K | 0.31% | 98 |
|
|
2020
Q4 | $407K | Buy |
5,215
+245
| +5% | +$18.7K | 0.33% | 92 |
|
|
2020
Q3 | $393K | Buy |
4,970
+1
| +0% | +$78 | 0.36% | 87 |
|
|
2020
Q2 | $367K | Sell |
4,969
-41
| -0.8% | -$3.09K | 0.36% | 85 |
|
|
2020
Q1 | $368K | Sell |
5,010
-209
| -4% | -$16.4K | 0.45% | 73 |
|
|
2019
Q4 | $453K | Sell |
5,219
-212
| -4% | -$17.4K | 0.42% | 85 |
|
|
2019
Q3 | $436K | Sell |
5,431
-50
| -0.9% | -$4.01K | 0.43% | 84 |
|
|
2019
Q2 | $439K | Sell |
5,481
-108
| -2% | -$8.27K | 0.44% | 83 |
|
|
2019
Q1 | $444K | Sell |
5,589
-155
| -3% | -$11.6K | 0.46% | 79 |
|
|
2018
Q4 | $419K | Buy |
+5,744
| New | +$405K | 0.52% | 72 |
|
Other funds holding MRK
Garrison Point Advisors's MRK Position: Q2 2026 in Review
Garrison Point Advisors reduced its Merck (MRK) stake by 8.3% in Q2 2026, selling an estimated $129K and leaving 12,116 shares worth $1.56M. The position accounts for 0.63% of the portfolio, ranked #45.
Garrison Point Advisors first reported a position in MRK in Q4 2018 and has held it in 31 quarters since. The position peaked at $1.85M in Q4 2024. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Garrison Point Advisors held 12,116 shares of Merck worth $1.56M as of Q2 2026.
- Garrison Point Advisors sold 1,100 Merck shares in Q2 2026, an estimated $129K.
- Merck made up 0.63% of Garrison Point Advisors's portfolio in Q2 2026, its #45 holding.
- Garrison Point Advisors first reported a position in Merck in Q4 2018 and has held it in 31 quarters since.
- Garrison Point Advisors's Merck position peaked at $1.85M in Q4 2024.
- 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Garrison Point Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.